
    
      Participants receiving Treatment A (fasting) will be dosed after having fasted overnight for
      at least 10 hours. Participants receiving Treatment B (fed; high-fat/high-calorie meal) will
      fast overnight for at least 10 hours then consume a Food and Drug Administration (FDA)
      standard high-fat, high-calorie breakfast beginning 30 minutes before dosing. Participants
      receiving Treatment C (fed; low-fat/low-calorie meal) will fast overnight for at least 10
      hours then consume an FDA standard low-fat, low-calorie breakfast beginning 30 minutes before
      dosing. The duration of the study is expected to be approximately 47 days.
    
  